Amcor Operating Cash Flow decreased by 63.0% to $186.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 59.0%, from $117.00M to $186.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -1.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $844.00M | -$112.00M | $435.00M | $266.00M | $937.00M | -$260.00M | $405.00M | $184.00M | $932.00M | -$135.00M | $363.00M | $150.00M | $943.00M | -$269.00M | $428.00M | $117.00M | $1.11B | -$133.00M | $503.00M | $186.00M |
| QoQ Change | — | -113.3% | +488.4% | -38.9% | +252.3% | -127.7% | +255.8% | -54.6% | +406.5% | -114.5% | +368.9% | -58.7% | +528.7% | -128.5% | +259.1% | -72.7% | +852.1% | -111.9% | +478.2% | -63.0% |
| YoY Change | — | — | — | — | +11.0% | -132.1% | -6.9% | -30.8% | -0.5% | +48.1% | -10.4% | -18.5% | +1.2% | -99.3% | +17.9% | -22.0% | +18.1% | +50.6% | +17.5% | +59.0% |